4//SEC Filing
Children's Hospital of Philadelphia Foundation 4
Accession 0001192482-17-000259
CIK 0001609351other
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 6:22 PM ET
Size
11.0 KB
Accession
0001192482-17-000259
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-09-27−6,000→ 0 total(indirect: By Affiliate)Exercise: $56.22From: 2017-06-01Exp: 2026-05-31→ Common Stock (6,000 underlying) - Exercise/Conversion
Common Stock
2017-09-27$56.22/sh+6,000$337,320→ 3,954,957 total - Exercise/Conversion
Stock Option (right to buy)
2017-09-27−20,250→ 0 total(indirect: By Affiliate)Exercise: $23.00Exp: 2025-01-30→ Common Stock (20,250 underlying) - Exercise/Conversion
Common Stock
2017-09-27$23.00/sh+20,250$465,750→ 3,948,957 total
Footnotes (2)
- [F1]This option was granted on January 30, 2015 to A. Lorris Betz, MD, Ph.D., a member of the Board of Trustees and Executive Committee of the Reporting Person and a former member of the Board of Directors of the Issuer. The option vests quarterly over four years. Dr. Betz holds this option for the benefit of the Reporting Person.
- [F2]This option was granted on June 1, 2016 to Dr. Betz, who holds this option for the benefit of the Reporting Person.
Documents
Issuer
Spark Therapeutics, Inc.
CIK 0001609351
Entity typeother
IncorporatedPA
Related Parties
1- filerCIK 0001632060
Filing Metadata
- Form type
- 4
- Filed
- Sep 26, 8:00 PM ET
- Accepted
- Sep 27, 6:22 PM ET
- Size
- 11.0 KB